7.59
Immatics N V Borsa (IMTX) Ultime notizie
Immatics (NASDAQ:IMTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Preferred dividends of Immatics N.V. – HAN:4A3 - TradingView
Behavioral Patterns of IMTX and Institutional Flows - Stock Traders Daily
Immatics (NASDAQ:IMTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeWhat's Next? - MarketBeat
Immatics stock falls 3.04 percent after cash raise and Q2 miss - AD HOC NEWS
Immatics stock holds at USD 8.77 as analysts see upside - AD HOC NEWS
Immatics stock holds steady as Q2 loss contrasts with strong cash position - AD HOC NEWS
Immatics (IMTX) Stock Forecast and Price Target 2026 - MarketBeat
Immatics N.V. (NASDAQ:IMTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Price-Driven Insight from (IMTX) for Rule-Based Strategy - Stock Traders Daily
Immatics N.V. (IMTX) Holds at $9.43 as Shares Consolidate Above Key SupportShort Term Trading Ideas - vinanet.vn
Immatics stock holds near USD 9.60 after market cap update - ad-hoc-news.de
Immatics N.V. Warrants (IMTXW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Immatics NV (IMTX) Peer Comparison – Compare with Others - Value Research
Immatics NV (IMTX) Key Financial Ratios – Valuation, Profitability & More - Value Research
Immatics NV (IMTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Immatics (NASDAQ:IMTX) Shares Up 5.3% on Insider Buying Activity - MarketBeat
Insider Buying: Immatics (NASDAQ:IMTX) Director Purchases 863,060 Shares of Stock - MarketBeat
Perceptive fund boosts Immatics (IMTX) stake with new open-market share buy - Stock Titan
Trading Systems Reacting to (IMTX) Volatility - Stock Traders Daily
Immatics (NASDAQ: IMTX) raises fresh cash to fund oncology pipeline - Stock Titan
Form 424B2 Immatics N.V. - streetinsider.com
Why is Immatics stock climbing today? - Investing.com India
Why is Immatics stock climbing today? By Investing.com - Investing.com Nigeria
Immatics downgraded to Buy due to partnership c... - Pluang
Why Immatics (IMTX) Is Down 5.4% After Mixed First‑Half 2026 Loss Trends And What's Next - simplywall.st
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
James Nelson Pepin Net Worth (2026) - GuruFocus
Immatics (NASDAQ:IMTX) Shares Down 8%Should You Sell? - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Immatics Announces Second Quarter 2026 Financial Results and Business Update - Sahm
Immatics (IMTX) awards counsel Nelson 225K share package - Stock Titan
Immatics Releases Q2 2026 Financial Results - AlphaStreet
Immatics Q2 revenue rises to $10.4 million - grafa.com
Immatics earnings on deck as analysts eye revenue trajectory By Investing.com - Investing.com India
Immatics earnings on deck as analysts eye revenue trajectory - Investing.com
Immatics Q2 Results: EPS misses estimate, sales up 93% YoY - scanx.trade
IMTX Looks 176.9% Overvalued on GF Value™ - GuruFocus
Immatics (NASDAQ:IMTX) Issues Earnings Results - MarketBeat
Immatics (IMTX) Slides 2.01% as Shares Approach Key $8.79 Support LevelQuality Factor - Vinanet
Immatics Posts Interim Q2 2026 Results and Updates Investor Materials - TipRanks
Immatics' Q2 Net Loss Narrows as Revenue Rises - marketscreener.com
Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, vs. FactSet Est of 10.4M Euros - marketscreener.com
Earnings Flash (IMTX) Immatics Posts Q2 Net Loss 0.46 Euros a Share, vs. FactSet Est of 0.45 Euros Loss - marketscreener.com
Immatics reports Q2 EPS (46c), consensus (48c) - TipRanks
Immatics: Q2 Earnings Snapshot - marketscreener.com
Immatics (NASDAQ: IMTX) posts €120m loss funding Phase 3 melanoma push - Stock Titan
Immatics N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Press Release: Immatics Announces Second Quarter 2026 Financial Results and Business Update - Moomoo
IMTX Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Pipeline InvestmentEPS Surprise History - vinanet.vn
Immatics (IMTX) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Preclinical and Clinical InvestmentConsensus Beat Rate - dars.gov.et
Immatics (IMTX): Baker Bros. group reports 9.5M-share, 7% ownership stake - Stock Titan
Genetically Reprogrammed T Cells Erase Terminal Kidney Cancer in Teen, NEJM Reports - Tech Times
Immatics NV (IMTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immatics N.V. expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Immatics N.V. (IMTX) Stock Analysis: Unveiling An 89.67% Potential Upside For Investors - DirectorsTalk Interviews
IMTX Q1 2026 Earnings: Wider-than-Expected Loss Reflects R&D-Driven BurnProfit Growth Outlook - dars.gov.et
How Immatics N.v. (IMTX) Affects Rotational Strategy Timing - Stock Traders Daily
Immatics (IMTX): Will Anzu-cel Take The PRAME Crown In Advanced Melanoma? - RTTNews
Immatics (IMTX) Expected to Release Quarterly Earnings on Wednesday - MarketBeat
Immatics (IMTX) Slips 5.9% to $8.66 as Biotech Selling Pressure IntensifiesLong Setup Ideas - careplusvn.com
Immatics N.V. (IMTX) Stock Analysis: Exploring a 105% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
Immatics Q1 2026 Earnings: EPS Misses Estimates as Pipeline Advances Offset Financial HeadwindsEarnings Revision Report - dars.gov.et
Immatics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):